Prognostic value of plasma D-dimer levels in lung carcinoma

Tumori

Volumn 97, Issue 6, 2011, Pages 743-748

  Komurcuoglu, Berna ^a   Ulusoy, Sadik ^b   Gayaf, Mine ^a   Guler, Arzu ^a   Ozden, Emel ^a  

^a Department of Chest Diseases   (Turkey)

^b ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

D dimer; Lung cancer; Prognosis; Survival

Indexed keywords

BLOOD CLOTTING FACTOR; CISPLATIN; D DIMER;

ADULT; AGE; AGED; ARTICLE; BLOOD CELL COUNT; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; INTERNATIONAL NORMALIZED RATIO; LUNG CANCER; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; PARTIAL THROMBOPLASTIN TIME; PATIENT SELECTION; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; SURVIVAL TIME; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD COAGULATION TESTS; CARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CHEMOTHERAPY, ADJUVANT; DISEASE PROGRESSION; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; INTERNATIONAL NORMALIZED RATIO; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PARTIAL THROMBOPLASTIN TIME; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTHROMBIN TIME; RADIOTHERAPY, ADJUVANT; TUMOR MARKERS, BIOLOGICAL;

EID: 84856920498     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1700/1018.11091     Document Type: Article

References (21)

1. Falanga A, Rickles FR: Pathophysiology of the thrombophilic state in cancer patient. Semin Tromb Hemost, 25: 173-182, 1999. (Pubitemid 29227146)
2. Kwaan HC, Keer HN: Fibrinolysis and cancer. Semin Tromb Hemost, 16: 230-235, 1990. (Pubitemid 20289930)
3. Bick RL: Coagulation abnormalities in malignancy: a review. Semin Tromb Hemost, 18: 596-602, 1992.
4. Oya M, Akiyama Y, Okuyama T, Ishikawa H: High preoperative plasma D-dimer level is associated with advanced tumor stage and short survival after curative resection in patients with colorectal cancer. Jpn J Clin Oncol, 31: 388-394, 2001.
5. Buccheri G, Torchio P, Ferrigno D: Plasma levels of Der in lung carcinoma. Cancer, 97: 1-9, 2003.
6. Unsal E, Atalay F, Atikcan S, Yilmaz A: Prognostic significance of hemostatic parameters in patients with lung cancer. Resp Med, 98: 93-98, 2004. (Pubitemid 38181125)
7. Altiay G, Ciftci A, Demir M, Kocak Z, Sut N, Tabakoglu E, Hatipoglu ON, Caglar T: High plasma D-dimer level is associated with decreased survival in patients with lung cancer. Clin Oncol, 19: 494-498, 2007. (Pubitemid 47181178)
8. World Health Organization: International Histological Classification of Tumors. Springer-Verlag, Berlin, 1991.
9. Mountain CF: Revisions in international system for staging lung cancer. Chest, 111: 1710-1717, 1997.
10. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, Mc- Fadden ET, Carbone PP: Toxicity and response criteria of Eastern Cooperative Oncology Group Study. Am J Clin Oncol, 5: 649-656, 1982.
11. Gasic GJ, Tuszynski GP, Goerlik E: Interaction of the haemostatic and immune systems in the metastatic spread of the tumor cells. Int Rev Exp Pathol, 29: 173-181, 1986.
12. Costantini V, Zacharski LR: Fibrin and cancer. Thromb Hemost, 69: 406-414, 1993. (Pubitemid 23146431)
13. Payev SJ, Hawson GA, Marsh NA: Impact of the fibrinolytic enzyme system on prognosis and survival assosiated with non small cell lung carcinoma. Blood Coagul Fibrinolysis, 12: 51-58, 2001. (Pubitemid 32150252)
14. Seitz R, Rappe N, Kraus M, Immel A, Wolf M, Maasberg M, Egbring R, Pfab R, Havemann K: Activation of coagulation and fibrinolysis in patients with lung cancer: relation to tumor stage and prognosis. Blood Coagul Fibrinolysis, 4: 249- 254, 1993.
15. Hagedorn AB, Bowie EJ, Elveback LR, Oven CA: Coagulation abnormalities in patients with inoperable lung cancer. Mayo Clin Proc, (Sep) 49: 647-653, 1974.
16. İnal S, Taci C, Karadurmu N, Kuzhan O, Balkan A, Özkan M, Bilgic H, Özet A, Ekiz K: The association of D-dimer levels with other prognostic factors in patients with lung cancer. Turk J Med Sci, 38: 209-217, 2008. (Pubitemid 351872818)
17. Gabazza EC, Taguchi O, Yamakami T, Machishi M, Ibata H, Suzuki S: Evaluating the prethrombotic state in lung cancer using molecular markers. Chest, 103: 196-200, 1993. (Pubitemid 23027258)
18. Taguchi O, Gabazza EC, Yasui H, Kobayashi T, Yoshida M, Kobayashi H: Prognostic significance of plasma D-dimer levels in patients with lung cancer. Thorax, 52: 563-565, 1997. (Pubitemid 27298511)
19. Ferrigno D, Buccheri G, Rica I: Prognostic significance of blood coagulation tests in lung cancer. Eur Respir J, 17: 667-673, 2001. (Pubitemid 32492555)
20. Pedersen LM, Milman N: Prognostic significance of thrombocytosis in patients with primary lung cancer. Eur Respir J, 9: 1826-1830, 1996.
21. Antoniou D, Pavlakou G, Stathopoulos GP, Karydis I, Chondrou E, Papageorgiou C, Dariotaki F, Chaimala D, Veslemes M: Predictive value of D-dimer plasma levels in response and progressive disease in patients with lung cancer. LungCancer, 53: 205-210, 2006. (Pubitemid 43994226)